August 14, 2017
1 min read
Save

Humeral component retroversion showed no impact on clinical outcomes of reverse shoulder arthroplasty

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Patients who underwent reverse shoulder arthroplasty with humeral retroversion of at least 20° had no differences in clinical or radiologic outcomes compared with patients who had humeral retroversion of no more than 10°, results showed.

Perspective from Patrick Noud, MD

Alexander W. Aleem, MD, and colleagues categorized 64 patients undergoing reverse shoulder arthroplasty with the Zimmer Trabecular Metal Reverse Shoulder System (Zimmer Biomet) based on whether they had humeral retroversion of 10° or less (group A) or humeral retroversion of 20° or greater (group B). Researchers compared clinical outcomes, including American Shoulder and Elbow Surgeons (ASES) scores, range of motion and internal rotation function, as well as radiographic outcomes, between the two groups.

A comparison of the groups showed no clinical or statistically significant differences in ASES scores, as well as no differences in range of motion or the ability to perform tasks that required shoulder internal rotation. However, researchers noted statistical and clinical improvements in both groups postoperatively compared with preoperative scores. At final follow-up, group A had an average score of 77.8 and group B had an average score of 79.2. – by Casey Tingle

 

Disclosures: Aleem has received research support from Zimmer Biomet. Please see the full study for a list of all other authors’ relevant financial disclosures.